Clinical Trial Update: A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TEV-48574 for moderate-to-severe ulcerative colitis or Crohn's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• TEV-48574

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Crohn Disease, Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2025-12-05